STS2 deficiency revives CD8+T cells from exhaustion and augments checkpoint blockade efficacy in cancer immunotherapy
Background T-cell exhaustion is a major barrier to effective antitumor immunity and limits the efficacy of cancer immunotherapies. This study investigates the role of suppressor of T-cell signaling 2 (STS2, also known as UBASH3A) in regulating CD8+ T-cell exhaustion within the tumor microenvironment...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
BMJ Publishing Group
2025-06-01
|
| Sraith: | Journal for ImmunoTherapy of Cancer |
| Rochtain ar líne: | https://jitc.bmj.com/content/13/6/e010735.full |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|